FLD vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 20, 2026

FLD

38.3
AI Score
VS
HIVE Wins

HIVE

49.5
AI Score

Investment Advisor Scores

FLD

38score
Recommendation
SELL

HIVE

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FLD HIVE Winner
Forward P/E 0 62.8931 Tie
PEG Ratio 0 0 Tie
Revenue Growth -25.5% 73.5% HIVE
Earnings Growth 1622.3% -99.9% FLD
Tradestie Score 38.3/100 49.5/100 HIVE
Profit Margin -258.6% -98.5% HIVE
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD HIVE

Relative Price Performance (Last 90 Days)

FLD 1M: +17.5% · 3M: +10.6% HIVE 1M: +9.4% · 3M: -12.0%

Current Technical Phase

FLD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.3% over 20 days), RSI 52

RSI (14): 52.5 · Price: $0.54

HIVE

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.6%) with fading momentum, RSI 46

RSI (14): 46.5 · Price: $2.98

Fundamentals Snapshot

Metric FLD HIVE
Market Cap — —
Forward P/E -1.3 -5.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.3% 0.7%
Gross Margin -0.5% 0.4%
Operating Margin -1.4% -0.6%
EPS -1.43 -1.39
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.